Cargando…
NRF2 Enables EGFR Signaling in Melanoma Cells
Receptor tyrosine kinases (RTK) are rarely mutated in cutaneous melanoma, but the expression and activation of several RTK family members are associated with a proinvasive phenotype and therapy resistance. Epidermal growth factor receptor (EGFR) is a member of the RTK family and is only expressed in...
Autores principales: | Kreß, Julia Katharina Charlotte, Jessen, Christina, Marquardt, André, Hufnagel, Anita, Meierjohann, Svenja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067606/ https://www.ncbi.nlm.nih.gov/pubmed/33916908 http://dx.doi.org/10.3390/ijms22083803 |
Ejemplares similares
-
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
por: Jessen, Christina, et al.
Publicado: (2020) -
The MAPK pathway as an apoptosis enhancer in melanoma
por: Haydn, Johannes M., et al.
Publicado: (2014) -
BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1
por: Grimm, Johannes, et al.
Publicado: (2018) -
Hypoxia-Independent Drivers of Melanoma Angiogenesis
por: Meierjohann, Svenja
Publicado: (2015) -
MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation
por: Meierjohann, Svenja, et al.
Publicado: (2010)